OLMA
Olema Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.75
+0.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 73.20x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.18x
- Price / sales
- —
- Price / cash flow
- -5.71x
Enterprise value
- Enterprise value
- $480.2M
- EV / sales
- —
- EV / EBITDA
- -2.35x
- EV / EBIT
- -2.17x
- Market cap
- $940.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026